The hsa-miR-1293 till now is known to target GCN1L1 (Table 5) and hsa-miR-1293 mediated down regulation of this tumor antigen gene (i.e. GCN1L1) could contribute to poor prognosis of the tumor [22]. This evidence concerns the gene LINC01194 and neoplasm.